To gain deeper understanding of the link between the effect of bevacizumab and the neutrophil count at baseline, we wondered whether GBM could secrete a growth factor for neutrophils such as Granulocyte-Colony Stimulating Factor (G-CSF). The gene discussed is CSF3; the disease is glioblastoma.